Orion OYJ Unsponsored ADR (OTCMKTS:ORINY) Stock Short Interest Report for October

Posted by Anthony Miller on Oct 26th, 2026

Orion OYJ Unsponsored ADR (OTCMKTS:ORINY – Get Free Report) was the target of a significant decline in short interest in the month of October. As of October 15th, there was short interest totaling 53 shares, a decline of 89.9% from the September 30th total of 526 shares. Currently, 0.0% of the shares of the stock are short sold. Based on an average daily trading volume, of 5,493 shares, the short-interest ratio is presently 0.0 days.

Orion OYJ Price Performance

OTCMKTS:ORINY traded up $1.73 during trading hours on Monday, reaching $55.85. 1,608 shares of the company were exchanged, compared to its average volume of 1,287. The company has a market capitalization of $15.76 billion, a P/E ratio of 22.98 and a beta of 0.07. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.64 and a quick ratio of 1.48. The business has a 50 day moving average of $46.72 and a 200 day moving average of $41.92. Orion OYJ has a 1-year low of $30.89 and a 1-year high of $55.85.

About Orion OYJ

(Get Free Report)

Orion Oyj, also known as Orion Corporation, is a Finnish pharmaceutical company that develops, manufactures and markets human and veterinary medicines. Its portfolio includes prescription medicines, over-the-counter products, generic pharmaceuticals and active pharmaceutical ingredients.

The company focuses on several therapeutic areas, including central nervous system disorders, oncology, respiratory diseases, pain management and veterinary medicine. Orion is particularly recognized for treatments related to Parkinson’s disease, as well as its Easyhaler line of inhaled medicines for respiratory conditions.

Founded in Finland in 1917, Orion is headquartered in Espoo.